MSEPT9 showed better performance than that of CEA and CA19-9 for CRC diagnosis, in which patients with CRC were distinguished from healthy individuals with a sensitivity of 72.94%, specificity of 81.97%, and AUC of 0.826. The gene discussed is CEACAM5; the disease is colorectal carcinoma.